Mustang Bio (MBIO) Capital Expenditures (2017 - 2023)

Mustang Bio (MBIO) has reported Capital Expenditures for 7 consecutive years, with $30000.0 the latest figure, recorded in Q4 2023.

• On a quarterly basis, Capital Expenditures fell 68.42% year-over-year to $30000.0 in Q4 2023; TTM through Sep 2024 was $30000.0, a 76.74% decrease from a year earlier, with the FY2023 full-year figure at $64000.0, down 97.64% from the prior year.
• Capital Expenditures was $30000.0 for Q4 2023 at Mustang Bio, up from $16000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $1.6 million in Q2 2021 and troughed at $16000.0 in Q2 2023.
• A 5-year average of $580736.8 and a median of $540000.0 in 2020 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 233.33% in 2021 and sank 98.65% in 2023, its largest moves.
• Over 5 years, Capital Expenditures stood at $891000.0 in 2019, then decreased by 21.77% to $697000.0 in 2020, then surged by 97.56% to $1.4 million in 2021, then sank by 93.1% to $95000.0 in 2022, then tumbled by 68.42% to $30000.0 in 2023.
• The last three Capital Expenditures figures came in at $30000.0 (Q4 2023), $16000.0 (Q2 2023), and $18000.0 (Q1 2023), per Business Quant data.